Table 1. Patient characteristics (n =... | American Society of Hematology

Table 1.

Patient characteristics (n = 150)

	No.	%
Sex, M/F	75/75	50/50
FAB
M0	6	4
1	19	13
2	46	31
3	8	5
4	41	27
5	20	13
6	2	1
7	7	5
No data	1	1
Cytogenetics	85	57
Normal	17	20
t(15;17)	6	7
t(8;21)	17	20
Abnormal 16*	13	15
Abnormal 11†	12	14
-7/7q-	3	4
+8	3	4
Other	14	16
Induction chemotherapy
Intensive timing	94	63
Standard timing	52	35
Intensive/standard timing	4	3
Splenomegaly at diagnosis
None	95	63
Enlarged	55	37
Hepatomegaly at diagnosis
None	95	63
Enlarged	55	37
Donor
Parent	11	7
Sibling	138	92
Unknown	1	1

	No.	%
Sex, M/F	75/75	50/50
FAB
M0	6	4
1	19	13
2	46	31
3	8	5
4	41	27
5	20	13
6	2	1
7	7	5
No data	1	1
Cytogenetics	85	57
Normal	17	20
t(15;17)	6	7
t(8;21)	17	20
Abnormal 16*	13	15
Abnormal 11†	12	14
-7/7q-	3	4
+8	3	4
Other	14	16
Induction chemotherapy
Intensive timing	94	63
Standard timing	52	35
Intensive/standard timing	4	3
Splenomegaly at diagnosis
None	95	63
Enlarged	55	37
Hepatomegaly at diagnosis
None	95	63
Enlarged	55	37
Donor
Parent	11	7
Sibling	138	92
Unknown	1	1

FAB indicates French-American-British classification.

Thirteen cases had inversion 16, 1 patient had a balanced translocation, and 1 had a partial deletion of chromosome 16.

All had abnormalities of 11q23.